Chris is the Director for the Life Sciences Practice at KPMG with a current focus on Asia markets. He is also a member of KPMG's Global Healthcare & Life Sciences practice with experience across a variety of jurisdictions and project types, such as commercial strategy, supply chain, workforce, technology, M&A, and compliance.
16/11/20 | Looking East: Debunking options for COVID-19 vaccine access 166 views
Emma is a Senior Consultant at ACG, Hong Kong, where she works closely with a range of healthcare providers, insurance, and pharma clients. Emma leverages her background in health policy and strategy to help organisations to achieve their objectives in healthcare excellence; often through major change projects and thought leadership. She is particularly interested enabling and spreading health-tech innovation within healthcare systems to improve quality and access equity. Prior to joining ACG, Emma worked under the NHS Graduate Management Scheme; the UK’s fast-track leadership scheme aimed at cultivating tomorrow’s healthcare Directors and CEO’s.
Emma developed her skills for consulting within a placement in KPMG’s Universal Health Coverage Team. She supported the Global Centre of Excellence to assess different paths to UHC and the current limitations and positives of these approaches. Emma undertook an MSc in Health Policy from Imperial College London, and a BSc in Medical Genetics from the University of Leicester.
27/05/20 | COVID-19 is spurring a digital health revolution - can private hospitals keep up? 171 views
Mabel C. Chou is an Associate Professor in the Department of Analytics and Operations at National University of Singapore (NUS) Business School.
The opinions expressed are those of the writer and do not represent the views and opinions of NUS.
19/05/20 | Better healthcare decisions depend on better data collection 91 views